Document Detail


Determinants of occurrence of aortic sclerosis in an aging population.
MedLine Citation:
PMID:  19679278     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We sought to identify clinical, physiological, and biochemical correlates, including markers of endothelial dysfunction and of tissue nitric oxide (NO) responsiveness, of the presence of aortic sclerosis (ASc) in an aging population. BACKGROUND: Aortic sclerosis has been regarded predominantly as a precursor of hemodynamically significant aortic stenosis. However, ASc also represents an independent correlate of increased risk of cardiovascular morbidity and mortality; the basis of this association is incompletely understood. The assumption that the pathogenesis of aortic valve disease is similar to that of atherosclerosis has not been supported by recent studies; rather there has been increasing evidence of a pathogenetic role of inflammation and endothelial dysfunction. Furthermore, we have recently developed methodology for echocardiographic quantitation of early aortic valve disease. METHODS: Randomly selected subjects (n = 253) ages 51 to 77 years underwent transthoracic echocardiography; aortic valve ultrasonic backscatter score (AV(BS)) was used to quantitate echogenicity of the aortic valve. Conventional coronary risk factors were identified. Integrity of NO generation/response was assessed via: 1) plasma asymmetric dimethylarginine concentrations, as a marker of endothelial dysfunction; 2) inhibition of platelet aggregation by the NO donor sodium nitroprusside, as a measure of tissue NO responsiveness and also a coronary prognostic marker; and 3) aortic augmentation index, as a measure of arterial stiffness/wave reflection. All putative correlations with AV(BS) were examined by univariate and multiple linear regression analyses. RESULTS: On the basis of AV(BS) scores, ASc was present in 19.4% of subjects. The AV(BS) directly correlated with patients' age but inversely correlated with high-sensitivity C-reactive protein, creatinine clearance, and platelet NO responsiveness. On multiple linear regression, ASc was associated with impaired platelet NO responsiveness (beta = -0.16, p = 0.02), advancing age (beta = 0.21, p = 0.003), and low body mass index (beta = -0.23, p = 0.001). CONCLUSIONS: Aortic sclerosis is associated with platelet NO resistance rather than conventional coronary risk factors: this might explain the increased thrombotic risk in ASc.
Authors:
Doan T M Ngo; Aaron L Sverdlov; Scott R Willoughby; Angus K Nightingale; Yuliy Y Chirkov; John J McNeil; John D Horowitz
Related Documents :
17028108 - Platelets and heart failure.
24188528 - Platelets of mice heterozygous for neurobeachin, a candidate gene for autism spectrum d...
6230918 - Role of platelet antagonists in coronary artery disease: implications in coronary arter...
2242448 - Molsidomine.
12019068 - Internal thiols and reactive oxygen species in candidacidal activity exerted by an n-te...
3157318 - Nifedipine in the treatment of raynaud's phenomenon. evidence for inhibition of platele...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JACC. Cardiovascular imaging     Volume:  2     ISSN:  1876-7591     ISO Abbreviation:  JACC Cardiovasc Imaging     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-14     Completed Date:  2009-10-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101467978     Medline TA:  JACC Cardiovasc Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  919-27     Citation Subset:  IM    
Affiliation:
University of Adelaide, South Australia, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aged
Aorta / physiopathology*
Aortic Valve / pathology*,  ultrasonography
Aortic Valve Stenosis / blood,  etiology*,  pathology,  physiopathology
Arginine / analogs & derivatives,  blood
Biological Markers / blood
Blood Platelets / drug effects,  metabolism*
Body Mass Index
Calcinosis / blood,  complications*,  pathology,  physiopathology
Cardiovascular Diseases / blood,  etiology*,  pathology,  physiopathology
Cross-Sectional Studies
Disease Progression
Echocardiography, Doppler
Elasticity
Endothelium, Vascular / metabolism,  physiopathology*
Female
Heart Valve Diseases / blood,  complications*,  pathology,  physiopathology
Humans
Linear Models
Male
Middle Aged
Nitric Oxide / metabolism
Nitric Oxide Donors / pharmacology
Nitroprusside / pharmacology
Platelet Aggregation / drug effects
Prospective Studies
Pulsatile Flow
Risk Assessment
Risk Factors
Sclerosis
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Nitric Oxide Donors; 10102-43-9/Nitric Oxide; 15078-28-1/Nitroprusside; 30315-93-6/N,N-dimethylarginine; 74-79-3/Arginine
Comments/Corrections
Comment In:
JACC Cardiovasc Imaging. 2009 Aug;2(8):928-30   [PMID:  19679279 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Central post-stroke pain: clinical characteristics, pathophysiology, and management.
Next Document:  Mechanisms of recurrent aortic regurgitation after aortic valve repair: predictive value of intraope...